Equity Research · Wednesday, September 9, 2026
RKLB Stock Analysis for September 2026
Rocket Lab Corporation Common Stock
Price at Analysis
1Y Price Target
$68.00
+3.2%
vs current price
Technical Setup
RSI 41 / bearish MACD
Support context: $37.57. Resistance context: $151.00.
Valuation Snapshot
P/E N/A (unprofitable; projected EPS growth 81% in 2026, 240% in 2027 per Zacks) / P/S ~45-50x trailing (per Aug 2026 reports at similar market cap)
Market cap $41.09B; revenue ~$769M TTM through June 2026; Q2 2026 record $234M (+60% YoY).
Risk Watch
Extreme valuation on unflown flagship
Review the full report for the primary downside scenario and risk factors.
01 · Summary
Executive Summary
Rocket Lab has corrected 56% from its $151 high, but the fundamentals have strengthened, not deteriorated: record Q2 2026 revenue of $234M (+60% YoY), record $2.4B backlog (45.5% converting within 12 months), and a transformational $8B Iridium acquisition that adds recurring cash-generating service revenue and completes vertical integration. The core bear argument I made in February — a $35B market cap on ~$600M of revenue with unproven Neutron economics — is partially resolved by ~90% revenue growth since then and contract wins ($456M suborbital, $816M satellite, $266M Space Force work) that don't depend on Neutron. However, this is not a clear buy. Even at $65.87, RKLB trades at roughly 45-50x trailing revenue on a business that remains unprofitable, and Neutron has slipped again — now targeting merely a pad delivery in Q4 2026 with no launch date, pushing first flight plausibly into 2027. The stock's decoupling from fundamentals during the SpaceX IPO halo, and its subsequent retrace, shows how sentiment-driven this multiple remains. The bad news is arguably priced in (as Seeking Alpha argues), but so is a lot of good news. I am shifting my stance from bear to neutral. The February thesis played out — the stock fell from ~$90s to $66 and the valuation risk partially materialized. Now the risk/reward is genuinely balanced: ~50x sales leaves little margin for Neutron failure, but the defense pivot, Iridium accretion, and 43%+ revenue CAGR through 2028 justify a target near current levels in 12 months with meaningful upside by 2029 if Neutron flies and margins mature.
02 · Scenario Modeling
Price Targets
$68.00+3.2%
$90.00+36.6%
1-Year scenario price targets · Dashed line = current price
02 · Scenario Modeling
Scenario Analysis
| Scenario | 1Y Target | 1Y Growth | 3Y Target | 3Y Growth |
|---|---|---|---|---|
↑↑Hyper Bull | $140.00 | +112.5% | $260.00 | +294.7% |
↑Bull | $85.00 | +29.0% | $130.00 | +97.4% |
→Neutral | $68.00 | +3.2% | $90.00 | +36.6% |
↓Bear | $45.00 | -31.7% | $55.00 | -16.5% |
↓↓Hyper Bear | $28.00 | -57.5% | $30.00 | -54.5% |
03 · Fundamentals
Key Financial Metrics
- Earnings Per Share (EPS)
- N/A (negative)
- Beta
- High (estimated ~1.8-2.0, high-growth momentum name)
- Revenue
- ~$769M TTM through June 2026; Q2 2026 record $234M (+60% YoY)
- P/E Ratio
- N/A (unprofitable; projected EPS growth 81% in 2026, 240% in 2027 per Zacks)
- P/S Ratio
- ~45-50x trailing (per Aug 2026 reports at similar market cap)
- Market Cap
- $41.09B
- Net Income
- Negative (losses widening on Neutron development costs)
- Dividend Yield
- 0%
- Short Interest
- N/A (elevated bearish commentary but no quantitative short interest data provided)
- 52-Week Low
- $37.57
- 52-Week High
- $151.00
02 · Scenario Modeling
Technical Overview
Quant overlays derived from the existing 1Y OHLCV series: trend stack, sigma bands, regression fit, drawdown regime, and a composite signal model.
RSI (14)
40.8
Momentum Stack
1M -20.5% / 3M -42.0%
Volatility Regime
38.9% 20D vol
Regression Fit
-30.0% vs trend
Drawdown Curve
Distance from rolling peak, useful for regime stress and recovery speed.
-56.2%
Trend Regime
bearish
Price < 50D < 200D
Composite Signal
bearish
Bearish (-4)
Mean Reversion
neutral
-0.74 sigma
Breakout Status
neutral
Inside channel
Range Percentile
bearish
25th pct
Volume Impulse
bullish
1.47x 20D avg
Quant Dashboard
A compact read on trend persistence, stretch, realized risk, and breakout behavior.
- 1M Return
- -20.5%
- 6M Return
- -7.8%
- 1Y Return
- N/A
- ATR (14)
- $3.01
- 20D Vol
- 38.9%
- 60D Vol
- 83.9%
- Regression R²
- 0.26
- Price Z-Score
- -0.74
- 52W High
- $151.00
- 52W Low
- $37.57
- Range Position
- 25th pct
- Latest Volume
- 24.4M
04 · Research
Micro Analysis
Rocket Lab is executing well operationally: 60%+ revenue growth, record backlog, strong gross margin, and defense wins that de-risk the model from Neutron. The Iridium acquisition adds ~$800M+ of recurring service revenue and cash flow. The one persistent failure mode is Neutron timing, which has slipped from 2024 to a mere pad-delivery target in Q4 2026, with launch possibly in 2027.
Record Q2 2026 results
$234M revenue (+~60% YoY vs $144M prior year), record gross margin, record backlog of $2.4B with 45.5% expected to convert within 12 months. Q3 guidance implies another record quarter.
Neutron slippage is chronic
Promised for 2024-2025, now targeting only pad delivery in Q4 2026; no launch date exists. The stock fell 24% in two weeks on the news, and first flight may slip to 2027. This has happened repeatedly and management credibility on this program is damaged.
Defense pivot de-risks the model
$456M in suborbital/hypersonic contracts that don't require Neutron, an $816M satellite contract, $266M Space Force deal, and $12M in SDN military contracts validate the vertically integrated 'space prime' strategy independent of launch.
Iridium acquisition is transformative
The $8B deal adds a recurring-revenue satellite operator, is expected to be accretive to cash flow and profitability (2027 profitability outlook intact per management), and completes end-to-end vertical integration from components to constellation operations.
Insider selling and burn
CFO sold 140k+ shares (~$8.8M) — pre-planned 10b5-1, retains 1.4M shares, so not a strong negative signal. Cash burn remains elevated from Neutron development with dilution risk flagged even by bulls.
04 · Research
Macro Analysis
The space economy is transitioning from speculative to strategic, driven by national security demand, but sentiment toward richly-valued space equities has cooled sharply since the SpaceX IPO sucked the air out of the trade.
SpaceX IPO halo reversed
The SpaceX IPO briefly inflated space valuations (RKLB hit $151); its share unlock in September 2026 and shifting sentiment against rich tech multiples triggered a sector-wide de-rating. RKLB fell 56% from highs largely on multiple compression, not fundamental deterioration.
Defense budgets favor new space primes
U.S. Space Force tactically responsive launch missions, NSSL opportunities, and hypersonic test demand structurally favor Rocket Lab's dual-use, vertically integrated model versus legacy contractors (which RKLB is demonstrably beating on contracts).
Valuation vs. growth tension
At ~$41B market cap and ~$800M trailing revenue (~50x P/S), RKLB is priced like a hyper-growth software company despite capital-intensive aerospace economics. Any deceleration from ~60% growth compresses the multiple violently.
Competitive field thickening
Intuitive Machines (LUNR) won Space Force GEO satellite work; STOKE, Relativity, and Firefly compete in launch. Rocket Lab's moat is vertical integration, but it is not uncontested.
05 · Growth
Untapped Revenue Opportunities
Iridium recurring service revenue
highThe $8B Iridium acquisition adds a cash-generative satellite services business, smoothing lumpy launch/manufacturing revenue and pushing the company toward 2027 profitability on a consolidated basis.
Defense & national security contracts
high$456M in suborbital hypersonic testing contracts plus $816M satellite and $266M Space Force wins demonstrate repeatable competitive wins; NSSL opens further if Neutron certifies.
Neutron medium-lift launch
highIf Neutron flies in 2027, it unlocks the $397M satellite contract, Amazon Kuiper-class constellation launches, and NSSL Phase 3 lanes — the single largest upside lever.
Space Systems components and constellations
medium70%+ of revenue from Space Systems (Photon, components) with 43% projected CAGR through 2028 as sovereign constellations proliferate.
06 · Catalysts
Headwinds & Tailwinds
↓ Headwinds
Extreme valuation on unflown flagship
highChronic Neutron execution risk
highCash burn and dilution
mediumSentiment-driven multiple
mediumIncreasing competition
low↑ Tailwinds
Record backlog with near-term conversion
highIridium accretion and 2027 profitability path
highVertical integration flywheel
mediumBad news substantially priced in
medium07 · TL;DR
Analysis Summary
- Ticker
- RKLB
- Company
- Rocket Lab Corporation Common Stock
- Analysis Date
- 2026-09-09
- Price at Analysis
- $65.87
- Rating
- Hold
- 1Y Price Target
- $68.00
- 3Y Price Target
- $90.00
- Market Cap
- $41.09B
- P/E Ratio
- N/A (unprofitable; projected EPS growth 81% in 2026, 240% in 2027 per Zacks)
This analysis was generated on 2026-09-09 when RKLB was trading at $65.87. The base-case 1-year price target is $68.00 (+3.2% implied return). Scenario range: $28.00 (hyper bear) to $140.00 (hyper bull).